首页> 外文期刊>International journal of immunogenetics >Association of cytokine Th2 gene polymorphisms with autoimmune thyroid diseases in Tunisian population
【24h】

Association of cytokine Th2 gene polymorphisms with autoimmune thyroid diseases in Tunisian population

机译:细胞因子TH2基因多态性与突尼斯人群自身免疫性甲状腺疾病的关联

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Autoimmune thyroid diseases (AITD) including Graves' disease (GD) and Hashimoto's thyroiditis (HT) are complex genetic diseases. Th2 cytokines act on the development of AITD. This study was conducted on Tunisian patients with AITD to investigate the association of Th2 cytokine gene polymorphisms and haplotype combination with GD or HT risk. A total of 156 controls, 160 patients with HT and 88 patients with GD were genotyped for IL‐4 rs2243250, IL‐5 rs2069812, IL‐6 rs1800796 and IL‐13 rs1800925 polymorphisms by PCR‐RFLP. The AITD risk was assessed by a logistic regression analysis using the SNP stats statistical program. False‐positive report probability (FPRP) was estimated to evaluate significant findings. IL‐13 rs1800925 was associated with GD, after adjustment for age and gender, in codominant, dominant and allele genetic models ( p ?=?.0072; p ?=?.0018; p ?=?.012, respectively). Significant association of the IL‐6 rs1800796C/G genotype with GD was also detected ( p ?=?.025). Furthermore, increased risk of HT was still found for IL‐13 rs1800925T allele ( p ?=?.039, OR?=?1.39) and for IL‐4 rs2243250T/T genotype both in codominant ( p ?=?.033, OR?=?2.59) and recessive ( p ?=?.011, OR?=?2.73) models after adjustment for age and gender. Interestingly, haplotype analysis performed on the IL‐4, IL‐5 and IL‐13 genes revealed a high risk of HT with CTT haplotype ( p ?=?.008, OR?=?2.12). However, the CCT haplotype is a protective factor (OR?=?0.36). Patients carrying the CT haplotype with only one minor allele had a moderate risk of HT (OR?=?1.56). The FPRP analysis showed that the association of IL‐13 rs1800925 polymorphism with GD and HT and the association of CTT haplotype with HT were noteworthy. In conclusion, the IL‐4, IL‐5, IL‐6 and IL‐13 polymorphism may play a role in susceptibility to GD and HT in the Tunisian population. Furthermore, gene–gene interaction between the IL‐4, IL‐5 and IL‐13 significantly increases the risk of AITD. Further studies with larger numbers of individuals are needed to confirm the results.
机译:摘要自身免疫性甲状腺疾病(AITD)包括Graves疾病(GD)和Hashimoto的甲状腺炎(HT)是复杂的遗传疾病。 TH2细胞因子对AITD的发展行为。该研究是在突尼斯患者对AITD进行的,以研究TH2细胞因子基因多态性和单倍型组合与GD或HT风险的关联。对于IL-4 RS2243250,IL-5 rs2069812,IL-6 rs1800796和IL-13 RS1800925和IL-13 RS1800925和IL-13 RS1800925多态性,共有156例HT和88例GD患者的GD患者进行了基因分型。通过使用SNP统计计划的Logistic回归分析评估AITD风险。估计假阳性报告概率(FPRP)评估重要发现。 IL-13 RS1800925与GD相关,调整年龄和性别后,在Codominant,显性和等位基因遗传模型中(P?= 0072; P?= 0018; P?= 012分别)。还检测了IL-6 RS1800796C / g基因型的显着关联(P?= 025)。此外,对于IL-13 RS1800925T等位基因,仍然发现HT的风险增加(P?= 039,或?=?1.39),并且在Codominant中用于IL-4 RS2243250T / T基因型(P?= 033或?=?2.59)和隐性(p?=Δ.011,或?=?2.73)调整年龄和性别后的模型。有趣的是,对IL-4,IL-5和IL-13基因进行的单倍型分析显示出HT与CTT单倍型的高风险(p?=Δ.008,或?2.12)。然而,CCT单倍型是保护因子(或?= 0.36)。携带CT单倍型的患者只有一个次要的等位基因的HT(或?=?1.56)的中等风险。 FPRP分析表明,IL-13 rs1800925多态性与GD和HT的关联和CTT单倍型与HT的关联是值得注意的。总之,IL-4,IL-5,IL-6和IL-13多态性可能在突尼斯人群中对GD和HT的易感性发挥作用。此外,IL-4,IL-5和IL-13之间的基因 - 基因相互作用显着提高了AITD的风险。需要更多的研究,以确认结果。

著录项

  • 来源
  • 作者单位

    Laboratory of Genetics Biodiversity and Bioresource ValorizationUniversity of MonastirMonastir;

    Laboratory of Genetics Biodiversity and Bioresource ValorizationUniversity of MonastirMonastir;

    Laboratory of Genetics Biodiversity and Bioresource ValorizationUniversity of MonastirMonastir;

    Laboratory of Transmissible Diseases and Biological Active Substances LR99ES27University of;

    Laboratory of Genetics Biodiversity and Bioresource ValorizationUniversity of MonastirMonastir;

    Laboratory of Genetics Biodiversity and Bioresource ValorizationUniversity of MonastirMonastir;

    Department of Internal Medicine‐EndocrinologyHospital Fattouma Bourguiba in MonastirMonastir Tunisia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 免疫性疾病;
  • 关键词

    autoimmune thyroid diseases; IL‐13; IL‐4; IL‐5; IL‐6; polymorphism;

    机译:自身免疫性甲状腺疾病;IL-13;IL-4;IL-5;IL-6;多态性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号